PURA Knockout hIPSC-ZZ Cell Line

The choice depends on whether you are studying PURA's role as a single-stranded DNA/RNA-binding transcription factor or modeling PURA syndrome (5q31.3 microdeletion or PURA point mutations) in a disease-relevant iPSC context. The Knockout line is the standard tool for asking whether PURA is required for these processes — PURA regulates myelin gene expression, neurodevelopment, and post-transcriptional control of specific mRNAs. Overexpression is useful for studying PURA's reported roles in stress granule formation and dendrite biology. For neurodevelopmental disease research, the EDITGENE PURA Knockout in hIPSC-ZZ is particularly valuable — induced pluripotent stem cells can be differentiated into neurons, astrocytes, and oligodendrocytes to recapitulate disease-relevant cell types. PURA syndrome is characterized by intellectual disability, hypotonia, seizures, and feeding difficulties. PURB paralog expression should be assessed given functional overlap. Rescue with wild-type or patient-derived mutant PURA enables genotype-function correlation studies in this disease-relevant iPSC platform — the principal advantage over conventional cell lines for neurodevelopmental disease modeling.

Primary applications: • Neuronal differentiation: directed differentiation of hIPSCs into cortical neurons, motor neurons, or oligodendrocytes followed by phenotypic and electrophysiological characterization in PURA-null versus rescued lines. • PURA syndrome modeling: rescue with patient-derived PURA mutations for genotype-function correlation studies of intellectual disability and neurodevelopmental phenotypes. • mRNA translation regulation: ribosome profiling and polysome analysis given PURA's role in translation control of specific mRNAs. • Myelin gene expression: oligodendrocyte differentiation and myelin gene (MBP, MOG) expression analysis given PURA's reported roles in myelin biology. EDITGENE recommends this model for researchers investigating PURA syndrome, neurodevelopmental disorders, and PURA-mediated post-transcriptional control. The iPSC background uniquely enables differentiation into disease-relevant neuronal lineages.

Yes. PURA rescue experiments require attention to hIPSC-specific considerations: • Construct design: use a codon-modified PURA sequence with a small N- or C-terminal tag (FLAG, HA, mCherry for imaging). PURA contains three PUR repeats that mediate single-stranded nucleic acid binding — preserve all elements. • iPSC-compatible promoters: use constitutive promoters resistant to silencing in iPSCs (e.g., EF1α, CAG, or hPGK) rather than CMV which is often silenced during differentiation. • Patient-derived mutation rescue: PURA syndrome-associated mutations (frameshift, missense, nonsense) introduced for genotype-function correlation studies in disease-relevant iPSC-derived cell types. • Functional readout: rescue should restore PURA-dependent translation regulation and, following neuronal differentiation, electrophysiological and morphological phenotypes characteristic of PURA-deficient neurons. hIPSC-ZZ supports lentiviral transduction; however, transgene silencing during differentiation is a known challenge — use silencing-resistant promoters and confirm transgene expression at multiple stages of differentiation. Verify pluripotency markers and karyotype stability after rescue line generation.